Trying New Things: The Rewards Usually Outweigh the Risk By Stacie Prada I’m realizing I have a pattern of planning ambitious goals or adventures when I’m feeling my lowest. My guess is that it...
Chemical compound produces beneficial inflammation, remyelination that could help treat multiple sclerosis
Chemical compound produces beneficial inflammation, remyelination that could help treat multiple sclerosisResearchers report that indazole chloride, a synthetic compound that acts on one form of the body’s estrogen receptors, is able to remyelinate (add...
Clinical outcome measures for progressive MS trialsMultiple Sclerosis Journal, Volume 23, Issue 12, Page 1627-1635, October 2017. … read morePosted At: MS Journal
Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis
Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosisMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Vitamin D no defense against dementiaNew research has shown that vitamin D (also commonly known as the sunshine vitamin) is unlikely to protect individuals from multiple sclerosis, Parkinson’s disease, Alzheimer’s disease or other brain-related...
Federal Government Shutdown’s Possible Impact on People with MS/About-the-Society/News/Federal-Government-Shutdown-s-Possible-Impact-on-P … read morePosted At: National MS Society
Join Our Mailing List
- Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis
- What are the early signs of MS?
- Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis
- Treatment decisions in MS: Shifting the goal posts or changing how we see them?
- How to give an intramuscular injection
- Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry
- e-Health and multiple sclerosis: An update
- Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System
- Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis
- MS: Is a ‘rogue’ brain and lymph node interaction to blame?